Retatrutide 30mg
$199.00
Skip to product information
Retatrutide 30mg
$199.00
| Specification | Details | |
|---|---|---|
| 🧪 | Size | 30 mg · 10 mL |
| ❄️ | Form | Lyophilized powder |
| 🇺🇸 | Manufactured | USA |
| 🧬 | Chemical Name | Triple agonist (GLP-1 / GIP / Glucagon Receptor) Peptide (LY3437943) |
| ⚛️ | Molecular Formula | C₂₂₆H₃₄₈N₅₄O₆₈ |
| ✅ | Purity | ≥98% (HPLC) — See Batch COA |
| 🧊 | Storage Conditions | Store at −20°C, desiccated, protected from light. Stable for up to 24 months in lyophilized form. |
| 🎯 | Receptor Activity | Triple agonist of GLP-1R, GIPR, and GCGR in HEK293 cAMP reporter assays with a balanced potency profile in metabolic pathway in vitro characterization. |
Retatrutide is an investigational triple agonist peptide that targets the GLP-1, GIP, and glucagon receptors. In preclinical and clinical research, it has been studied for its effects on metabolic pathways involved in body weight regulation, glucose metabolism, and energy balance. Retatrutide is intended for laboratory and research use only and is not approved for human or veterinary use.